In this study, we describe the synthesis of 1,4-disustituted-1,2,3-triazolo-ribonucleosides by means of 1,3-dipolar cycloaddition between various N-1 propargyl-pyrimidines and 1'-azido-2',3',5'-tri-O-benzoylribose catalyzed by Na2CuP2O7/sodium ascorbate. All obtained compounds were evaluated for their anti-HCV activity in vitro.
Introduction
Triazole derivatives occupy a prominent place in medicinal chemistry because of their therapeutic properties. Compounds containing a triazole moiety have found tremendous application in the field of pharmaceutical, 1 biology, 2 and material sciences. 3 On the other hand, triazole nucleosides such as Ribavirine (Virazole) or 1,2,3-triazole TSAO analogues are used for the treatment of HCV and HIV 4, 5 respectively. Thus, the pharmaceutical importance of triazoles has prompted the design and synthesis of various triazolonucleosides. [6] [7] We previously reported the preparation of various 1,2,3-triazole acyclonucleosides from the propargylated nucleobases by copper-free Huisgen 1,3-dipolar cycloaddition at high temperature and long duration and the evaluation of the resulting compounds for their HIV activity. 8 Recently, we also reported the preparation of several triazoloacyclic nucleoside phosphonates using copper(I)-catalyzed Huisgen 1,3-dipolar cycloaddition between azidoalkylphosphonates and propargylated nucleobases and their evaluation for their HIV and HCV activity. 9 The click reaction 10 has become a basic tool in organic or in bioorganic for the preparation of 1,2,3-triazole. To reach this aim, a number of procedures have been developed including the use of Cu(I)-Zeolite 11 , Cu/C 12 , Cu(OH)x/TiO2 13 . The results obtained by any of these methods are, in general, excellent. On the other hand, looking for a new catalyst having a great efficiency to carry on the 1,3-dipolar cycloaddition reaction is still in demand.
In addition to our previous research on using phosphate derivatives as catalyst 14 and in continuation of our drug discovery program, we report herein the synthesis of new 1,4-disubstituted-1,2,3-triazolo-ribonucleosides using, for the first time, Na 2 CuP 2 O 7 as catalyst for Huisgen 1,3-dipolar cycloaddition. The anti-HCV activity of the prepared 1,2,3-triazole ribonucleosides was also determined.
Results and Discussion
After a series of trials with various copper catalysts, we were pleased to find that Na2CuP2O7 could be used for the smooth preparation of 1,4-substituted 1,2,3-triazole nucleosides under mild conditions. The synthetic phosphate Na2CuP2O7 was prepared by reaction between Na2CO3, CuO and (NH4)2HPO4 as previously reported 15 . The final product was identified by X-ray powder diffraction using a Siemens D-500 diffractometer (CuKα radiation 1.5406 Å; Space group: triclinic P1bar; a = 5.361 Å, b = 7.029 Å and c = 8.743 Å) and infrared spectroscopy IR. FTIRspectrum of the Na2CuP2O7 compound exhibited prominent multiple absorption bands especially in three frequency regions (i.e. at ν1 = 2350.6 cm−1, ν2 = 1629.7 cm −1 and ν3 = 1260-499.3 cm −1 ). The vibration at 2350.6 cm −1 is attributed due to the stretching of Cu O Cu bonding and 1629.7 cm −1 is due to the stretching of Na O bonding. The strong vibration bands in the range of 1260-499.3 cm −1 are due to the presence of P O P bonding. We have developed a new and easy synthesis of the propargyl pyrimidines and purine using K2CO3/Natural Phosphate (1/5) as a basic catalyst 14 (Scheme 1). The yields obtained were 45 to 65% after 2 to 3 h. The major advantage of this method is the ease of the work-up. This procedure appears to be regioselective and gives only the N-1 isomer for pyrimidines and N-9 isomer for adenine ( Table 1 ). The structures of the nucleosides 2a-h were determined from their spectral (NMR 1 H, 13 C, and Mass) data and found to be in agreement with the literature 8d .
BH= base: Uracil 1a, 5-F-uracil 1b, 5-Cl-uracil 1c, 5-Br-uracil 1d,5-I-uracil 1e, Thymine 1f, 6-Azauracil 1g, Adenine 1h. In preliminary experiments, azido-2,3,5-tri-O-benzoylribose 16 (azidosugar) 3 was chosen for the template reaction with propargyl-uracil 2a. Initially, Na2CuP2O7 was used alone, with Dioxane/Water (2/1, V/V) as solvent. No product was isolated when the reaction was conducted at room temperature overnight in the presence of 10 mol% Na2CuP2O7 (entry 1, Table 2 ). Therefore, we tried heating and increasing the amount of Na2CuP2O7. To our delight, the reaction gave the corresponding 1,2,3-triazole nucleoside 4a in a range of 15-26% yield (entries: 2-5, Table 2 ) at 90°C. We decided to explore the feasibility of the 'click' chemistry with the novel catalyst Na2CuP2O7 for the construction of novel 1,2,3-triazole nucleosides. In the standard procedure for regioselective Cu(I)-catalyzed alkyne-azide coupling, the catalyst can be directly introduced as a Cu(I) salt or generated in situ by reduction of a Cu(II) salt, usually in organicaqueous systems 17 . Two reaction conditions that favour either process were selected: Condition A 18 : azidosugar + propargyl-uracil + Na2CuP2O7 (0.5mmol) + (Et)3N + Dioxane/water (90°C, 2h): these conditions produced no reaction . Condition B:
azidosugar + propargyl-uracil + Na 2 CuP 2 O 7 (0.5mmol)/Na Ascorbate(0.5 mmol) + Dioxane/water (90°C, 2h) . Condition B gave the 1,2,3-triazole nucleoside 4a with 72% yield.
Encouraged by this result, the reaction was carried out increasing the amount of Na ascorbate(0.1 mmol-1 mmol) the optimal reaction condition was as follows: Na 2 CuP 2 O 7 (0.5 mmol)/Na Ascorbate(0.5 mmol) as catalyst and Dioxane/water(2/1, v/v) as solvent and reflux 90°C for 2 h. We deduced that the catalyst is generated in situ from Cu(II) (Na2CuP2O7) via reduction with sodium ascorbate. Under the present conditions when simpler alkyne 5 was used in the reaction with the azides 3a or 3b (Scheme 2, 3) led to the corresponding 1,4-disubstituted 1,2,3-triazole derivatives 6, and 7 in 66% and 62% yields respectively as shown in Table 3 . These results are in the same range as those reported in the literature 19 using CuSO4/Na Ascorbate as catalyst for the preparation of 1,2,3-triazolo-nucleosides.
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The optimised reaction conditions were successfully applied to a variety of terminal alkynes (Table 4) . Propargylated uracil, 5-fluorouracil, 5-chlorouracil, 5-bromouracil, 5-iodouracil, thymine, 6-azauracil, and adenine were combined with azidosugar 3. All reactions were highly regioselective towards the corresponding 1,2,3-triazole nucleosides 8a-h and were obtained in excellent isolated yields (Table 4) . Deblocking of the benzoyl protecting groups was performed using methanolic ammonia (saturated at 0°C) at room temperature and gave 1,2,3-triazole ribonucleosides 9a-h in a 40-55% yield. The structures of the nucleosides were determined from their spectral ( 1 H, 13 C NMR and Mass) data. The mechanism for this Na2CuP2O7 -catalyzed synthesis of 1,2,3-triazole ribonucleosides need much more studies, but we offer the following tentative hypothesis. A plausible mechanism (Scheme 6) might follow the same steps as for a bimetallic mechanism where the alkyne was coordinated to one Cu center, and the azide interacts with the second Cu center. 20 Finally, we were also interested in studying the biological activity of 1,2,3-triazole ribonucleosides 9a-h. These derivatives were tested in vitro in the aim to evaluate their anti-HCV activity. None of the new compounds were found to inhibit HCV replication in vitro (Table  5) .
Antiviral activity was assessed in a 3 day cell culture assay using the HCV-replicon-containing cell line, AVA5 (genotype 1b, CON1) (provided by Apath, Inc. to GUMC) as previously described 21 .
Finally, we were also interested in studying the biological activity of 1,2,3-triazole ribonucleosides 9a-h. These derivatives were tested in vitro with the aim to evaluate their anti-HCV activity. None of the new compounds were found to inhibit HCV replication in vitro (Table  5) . 1 mmol) , Na2CuP2O7(0.5 mmol) Na ascorbate (0.5 mmol) in dioxane/water at 90°C.
b Isolated yield after column chromatography. 
Conclusions
We have shown for the first time that 1,4-disubstituted 1,2,3-triazole ribonucleosides can be prepared from protected azidosugar 3 and propargyl-nucleobases 2a-h by using the couple Na2CuP2O7/Na ascorbate as a new catalyst. The major advantages of this method is the ease of the work-up, short reaction times and use of various substrates which make it a useful strategy for the synthesis of 1,2,3-triazole ribonucleosides in comparison to high temperature cycloaddition 8 which resulted in a mixture of regioisomers.
Experimental Section
General. The NMR spectra were recorded on a Bruker spectrometer (AC 300 MHz). Chemical shifts are reported as δ values (ppm) relative to TMS as a standard and the coupling constants J values are given in Hz. FAB mass spectra were recorded on a Varian MAT 311A spectrometer. TLC was performed on 60 F254 precoated plastic plates silica gel (Merck). Column chromatography was performed on silica gel (30-60 μm). All solvents were distilled and dried before using.
Preparation of K2CO3/NP 500 mg of K2CO3 were dissolved in 5 ml of water and then 2.5 g of Natural Phosphate (NP) were added to the solution. After 15 min stirring, the mixture was evaporated to dryness and used as catalyst.
Typical procedure for alkylation reactions
To a mixture of nucleobase (1 mmol), 200 mg of the catalyst K2CO3/NP (1/5) and 5ml of CH3CN was added propargyl bromide (1.1 mmol).The latter, was heated under reflux. After 30 min heating, an additional 100 mg of K2CO3/NP were added. After 2 to 3 h heating the reaction was quenched by adding two drops of acetic acid, and filtered. The precipitate was washed with MeOH. The solvent was evaporated and the residue was purified by flash column (silica gel) ( Table 1 ).
Typical procedure for 1,3-dipolar cycloaddition
The propargylated base 2a-h (1.1 mmol), azidosugar 3 (1 mmol) and Na2CuP2O7 (0.5 mmol), sodium ascorbate (0.5 mmol) were suspended in Dioxane/water (2/1, v/v) and stirred at reflux 90°C for 2 h. Then, the solution was evaporated, and the residue was applied to flash column (silica gel). -benzyl-1H-1,2,3-triazole-4-carboxylate (7) . 
Ethyl-[(2,3,5-Tri-O-benzoyl-ß-D-erythro-pentofuranosyl)-1,2,3-triazol]-4-carboxylate (6

